Latest Funding News

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

Elevate Uranium Ltd has expanded its global uranium resource to 169 million pounds of U3O8 through the acquisition of the Napperby Uranium Project and complementary assets from Core Lithium Ltd. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.

MRG Metals has raised $0.73 million through a placement to advance its rare earth and heavy mineral sands projects in Mozambique and South Africa, including a strategic acquisition and mining license progression.

MRG Metals has completed the acquisition of the Garies Rare Earth Project, a high-grade, magnet-rich rare earth asset in South Africa, significantly boosting its critical minerals portfolio. The deal positions MRG for rapid development with a clear pathway to early cashflow and complements its existing projects in Mozambique and the Adriano–Fotinho corridor.

Kairos Minerals has reported compelling drill results from its Mt York Gold Project, highlighting significant gold intercepts that underpin an upcoming resource update scheduled for early 2026.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.

Rox Resources has completed a $200 million capital raise, including a $134 million second tranche placement, to fund development of its Youanmi Gold Project in Western Australia.

Minbos Resources has obtained a crucial ASX waiver allowing it to issue shares under its Share Purchase Plan without the usual shareholder approval, aligning pricing with its recent Placement and aiming to maintain fairness among investors.

Nova Minerals Limited has successfully closed a $20 million underwritten public offering on NASDAQ, aiming to accelerate exploration and development at its Estelle Gold and Critical Minerals Project in Alaska.

Earlypay Limited has withdrawn its FY26 earnings guidance due to increased costs and credit losses, signaling a cautious outlook despite solid growth in new business.

Pearl Gull Iron has completed the sale of its Cockatoo Island Project, receiving $4.5 million in cash, a 4% indirect stake in Crestlink Pty Ltd, and ongoing royalties. The transaction positions the company to pursue new growth opportunities while maintaining exposure to the project’s future upside.